Efficacy and safety of tocilizumab in Chinese patients with systemic juvenile idiopathic arthritis: a multicentre phase IV trial
Clin Rheumatol. 2024 Sep 16. doi: 10.1007/s10067-024-07126-9. Online ahead of print. ABSTRACT OBJECTIVES: Given the limited tocilizumab (TCZ) treatment data for systemic juvenile idiopathic arthritis …